Overview
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Total raised
$20.9M
2 rounds on record
Latest round
$5M
Venture round · Jan 2025 · 20 mo ago
Team
51-200
employees, estimated range
Backers
1
OrbiMed
The money's age
Due for its next round
20 months since the last round · not hiring
Momentum
0/100
no fresh signals
Funding rounds
RoundDateAmountInvestorsSource
Venture round Jan 2025 $5M — SEC Form D
Venture round Dec 2022 $15.9M — SEC Form D
Registers and programsofficial lists and records that name the company
Legal entity Aer Therapeutics, Inc. sec
Founders and leadersfrom filings, registers and the company's site
James ShafferExecutive Officer, DirectorSEC Form D
Thomas MathersExecutive Officer, DirectorSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
Similar startupsby what they do, their industry and backers
TrajectoryVenture round $15M · 3 mo ago
-Our Mission 誰もが空の恩恵を享受できる世界を実現する トラジェクトリーは、管制の自動化を通じて、誰もが安全かつ簡単に無人航空機の恩恵を享受できる社会を実現し、人々のQOL(Quality of Life)の向上に貢献するというミッションを掲げています。.
Alpheus MedicalSeries B $52M · 16 mo ago • Founded 2020 • 51-200 employees
Alpheus is advancing a new therapeutic approach designed to improve outcomes while reducing treatment burden for patients and families.
Serca PharmaceuticalsFounded 2018 • 201-500 employees
Our mission is to improve the quality of life of patients with myocardial infarction (MI) and heart failure by providing novel…
Sanity GroupFounded 2018 • 9 roles
Berlin-based Sanity Group is one of Europe's leading cannabis companies and aims to improve people’s quality of life through the use of…
Perfuse TherapeuticsVenture round $9M · 6 yr ago • Founded 2018 • 51-200 employees
Perfuse Therapeutics is developing a product to improve blood flow to the retina, the most metabolically demanding tissue in the human body.
DELFI DiagnosticsVenture round $225M · 4 yr ago • Founded 2019 • 51-200 employees • 5 roles
FirstLook Lung is a blood-based test that helps identify lung cancer risk before or alongside LDCT, for USPSTF-eligible adults. From DELFI…

Overview

AER Therapeutics is developing mucolytic treatments that target mucus plugs in COPD and asthma to improve lung function and quality of life.

People

James Shaffer
Executive Officer, Director
Thomas Mathers
Executive Officer, Director
Tim Shannon
Director
Christy Shaffer
Director
Rishi Gupta
Director
John Fahy
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove

Offices

Where the company hires and what each office is for
Cities
2
Hiring now
0
Countries
1
Raleigh United States
HQ
400 W North Street,, Suite 112, Raleigh NC 27603
company site
Park United States
Regional office
8 Davis Dr, Research Triangle Park, NC 27709
company site

Financials

Total raised
$20.9M
Latest round
Venture - Series Unknown
Funding rounds
2
Funding rounds
Round Announced Amount
Venture - Series Unknown 2025 $5M Details
Venture - Series Unknown 2022 $15.9M Details